How has been the historical performance of Maitreya Medica.?

Answer:The historical performance of Maitreya Medica shows a fluctuating trend in key financial metrics over the past four years. Breakdown: Maitreya Medica's net sales have seen a decline from INR 49.41 crore in March 2022 to INR 46.66 crore in March 2025, with a slight increase in March 2023 to INR 39.38 crore before a small recovery in March 2024. Total operating income followed a similar pattern, peaking in March 2022 and then declining to INR 46.66 crore in March 2025. The total expenditure, excluding depreciation, decreased from INR 46.05 crore in March 2022 to INR 41.80 crore in March 2025, contributing to an operating profit (PBDIT) of INR 4.86 crore in March 2025, down from INR 7.25 crore in March 2023. Profit before tax also decreased from INR 5.93 crore in March 2023 to INR 3.21 crore in March 2025, leading to a profit after tax of INR 1.87 crore in March 2025, down from INR 4.25 crore in March 2023. The company's total assets increased from INR 24.49 crore in March 2022 to INR 47.99 crore in March 2025, while total liabilities rose from INR 24.49 crore to INR 47.99 crore in the same period. Cash flow from operating activities improved to INR 5 crore in March 2025, compared to a negative cash flow of INR 2 crore in March 2024, indicating a recovery in operational efficiency. Overall, Maitreya Medica has experienced fluctuations in sales and profitability, but has shown growth in total assets and cash flow from operations.